TrueBlue, Inc.

NYSE:TBI Rapport sur les actions

Capitalisation boursière : US$202.8m

TrueBlue Croissance future

Future contrôle des critères 3/6

TrueBlue devrait augmenter ses bénéfices et son chiffre d'affaires de 112.8% et de 0.2% par an respectivement. Le BPA devrait croître de de 112.7% par an. Le rendement des capitaux propres devrait être 6.1% dans 3 ans.

Informations clés

112.8%

Taux de croissance des bénéfices

112.7%

Taux de croissance du BPA

Professional Services croissance des bénéfices15.7%
Taux de croissance des recettes0.2%
Rendement futur des capitaux propres6.1%
Couverture par les analystes

Low

Dernière mise à jour05 Nov 2024

Mises à jour récentes de la croissance future

Recent updates

Benign Growth For TrueBlue, Inc. (NYSE:TBI) Underpins Its Share Price

Jul 17
Benign Growth For TrueBlue, Inc. (NYSE:TBI) Underpins Its Share Price

Is TrueBlue, Inc. (NYSE:TBI) Trading At A 34% Discount?

Feb 23
Is TrueBlue, Inc. (NYSE:TBI) Trading At A 34% Discount?

TrueBlue: A Suspect Rebound

Dec 14

TrueBlue: Failing Strategy And Market Share Loss

Oct 10

TrueBlue's Q2 2023 Woes: Blue Skies Turn Grey

Jul 25

Here's What's Concerning About TrueBlue's (NYSE:TBI) Returns On Capital

May 23
Here's What's Concerning About TrueBlue's (NYSE:TBI) Returns On Capital

When Should You Buy TrueBlue, Inc. (NYSE:TBI)?

Apr 26
When Should You Buy TrueBlue, Inc. (NYSE:TBI)?

TrueBlue: Low Unemployment Is Not Good News For This Staffing Company

Feb 17

TrueBlue GAAP EPS of $0.21 misses by $0.07, revenue of $558M misses by $4.93M

Feb 01

At US$19.89, Is It Time To Put TrueBlue, Inc. (NYSE:TBI) On Your Watch List?

Dec 08
At US$19.89, Is It Time To Put TrueBlue, Inc. (NYSE:TBI) On Your Watch List?

TrueBlue GAAP EPS of $0.63 beats by $0.03, revenue of $576M misses by $11.22M

Oct 24

TrueBlue names Taryn Owen President, COO

Sep 28

TrueBlue GAAP EPS of $0.72 beats by $0.33, revenue of $569.25M misses by $3.52M

Jul 25

Is TrueBlue (NYSE:TBI) A Risky Investment?

Jul 22
Is TrueBlue (NYSE:TBI) A Risky Investment?

Investors Met With Slowing Returns on Capital At TrueBlue (NYSE:TBI)

Jul 01
Investors Met With Slowing Returns on Capital At TrueBlue (NYSE:TBI)

Is Now An Opportune Moment To Examine TrueBlue, Inc. (NYSE:TBI)?

Jun 11
Is Now An Opportune Moment To Examine TrueBlue, Inc. (NYSE:TBI)?

The Returns On Capital At TrueBlue (NYSE:TBI) Don't Inspire Confidence

Mar 08
The Returns On Capital At TrueBlue (NYSE:TBI) Don't Inspire Confidence

TrueBlue (NYSE:TBI) Is Finding It Tricky To Allocate Its Capital

Nov 15
TrueBlue (NYSE:TBI) Is Finding It Tricky To Allocate Its Capital

Is There An Opportunity With TrueBlue, Inc.'s (NYSE:TBI) 29% Undervaluation?

Sep 22
Is There An Opportunity With TrueBlue, Inc.'s (NYSE:TBI) 29% Undervaluation?

Is It Too Late To Consider Buying TrueBlue, Inc. (NYSE:TBI)?

Jul 28
Is It Too Late To Consider Buying TrueBlue, Inc. (NYSE:TBI)?

TrueBlue (NYSE:TBI) Has Some Difficulty Using Its Capital Effectively

Jul 05
TrueBlue (NYSE:TBI) Has Some Difficulty Using Its Capital Effectively

Prévisions de croissance des bénéfices et des revenus

NYSE:TBI - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20261,7302561811
12/31/20251,553-433563
12/31/20241,566-122-36-123
9/29/20241,674-117-35-8N/A
6/30/20241,764-109-31-2N/A
3/31/20241,844-12-1911N/A
12/31/20231,906-14335N/A
9/30/20231,972-52960N/A
6/25/20232,074165688N/A
3/26/20232,1684770103N/A
12/25/20222,2546290121N/A
9/25/20222,3187571100N/A
6/26/20222,32073-326N/A
3/27/20222,26665-1219N/A
12/26/20212,17462-1520N/A
9/26/20212,070491554N/A
6/27/20211,968406196N/A
3/28/20211,81116123153N/A
12/27/20201,846-142125153N/A
9/27/20201,919-141114140N/A
6/28/20202,081-123131160N/A
3/29/20202,311-9670100N/A
12/29/20192,369636594N/A
9/29/20192,4286985110N/A
6/30/20192,4716792113N/A
3/31/20192,4976581102N/A
12/30/20182,49966109126N/A
9/30/20182,519677288N/A
7/1/20182,49964N/A85N/A
4/1/20182,49560N/A91N/A
12/31/20172,50955N/A100N/A
10/1/20172,57457N/A129N/A
7/2/20172,61059N/A142N/A
4/2/20172,673-18N/A155N/A
1/1/20172,751-15N/A261N/A
9/23/20162,826-5N/A165N/A
6/24/20162,813-9N/A150N/A
3/25/20162,76872N/A137N/A
12/25/20152,69671N/A72N/A
9/25/20152,57670N/A108N/A
6/26/20152,52671N/A125N/A
3/27/20152,35170N/A120N/A
12/26/20142,17466N/A48N/A
9/26/20141,93253N/A101N/A
6/27/20141,74951N/A91N/A
3/28/20141,71848N/A103N/A
12/27/20131,66945N/A86N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: TBI devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance plus rapide que le taux d'épargne ( 2.6% ).

Bénéfices vs marché: TBI devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance supérieure à la moyenne du marché.

Croissance élevée des bénéfices: TBI devrait devenir rentable dans les 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de TBI ( 0.2% par an) devrait croître plus lentement que le marché de US ( 9% par an).

Croissance élevée des revenus: Le chiffre d'affaires de TBI ( 0.2% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de TBI devrait être faible dans 3 ans ( 6.1 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y